Highlights in PAH presented at the 2020 ATS International Conference

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Healio spoke with Adriano Tonelli, MD, pulmonologist at Cleveland Clinic, about research highlighted at the ATS 2020 meeting on risk stratification, dual vs. triple combination therapy and switching medications in prostacyclin analog treatment.

Click here to watch the next video in the series on managing patients with different severities of PAH.

Published by:

Sources/Disclosures

Collapse

Disclosures: Tonelli reports no relevant financial disclosures.

Read more about

pulmonary arterial hypertension

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment